Operating Lease, Right-of-Use Asset of Strata Critical Medical, Inc. from 30 Jun 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Strata Critical Medical, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Jun 2020 to 30 Sep 2025.
  • Strata Critical Medical, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $3,274,000, a 86% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Strata Critical Medical, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $3,274,000 -$19,539,000 -86% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $8,453,000 -$12,670,000 -60% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $8,650,000 -$15,926,000 -65% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $2,831,000 -$20,653,000 -88% 31 Dec 2024 10-Q 10 Nov 2025 2025 Q3
Q3 2024 $22,813,000 -$477,000 -2% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $21,123,000 -$2,063,000 -8.9% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $24,576,000 +$484,000 +2% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $23,484,000 +$5,792,000 +33% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 $23,290,000 +$6,346,000 +37% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $23,186,000 +$17,183,000 +286% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $24,092,000 +$23,134,000 +2415% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $17,692,000 +$16,979,000 +2381% 31 Dec 2022 10-K 12 Mar 2024 2023 FY
Q3 2022 $16,944,000 +$16,290,000 +2491% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $6,003,000 +$5,545,000 +1211% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $958,000 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $713,000 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 $654,000 -$83,000 -11% 30 Sep 2021 8-K 10 Jan 2023
Q2 2021 $458,000 -$279,000 -38% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q3
Q3 2020 $737,000 30 Sep 2020 10-K 20 Dec 2021 2021 FY
Q2 2020 $737,000 30 Jun 2020 10-Q 16 Aug 2021 2021 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.